# Giampaolo Talamo

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/giampaolo-talamo/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,156 |
| Field | Multiple Myeloma Research and Treatments |
| h-index | 24 |
| i10-index | 43 |
| Last Known Institution | SUNY Upstate Medical University |
| OpenAlex ID | https://openalex.org/A5003442418 |
| ORCID iD | 0009-0000-1781-1633 |
| Works | 122 |

## Researcher papers

- [Thalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma](https://scholariq.org/papers/thalidomide-and-hematopoietic-cell-transplantation-for-multiple-myeloma/)
- [The acute promyelocytic leukemia-specific PML-RARα fusion protein inhibits differentiation and promotes survival of myeloid precursor cells](https://scholariq.org/papers/the-acute-promyelocytic-leukemia-specific-pml-rar-fusion-protein-inhibits/)
- [Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation](https://scholariq.org/papers/deep-vein-thrombosis-in-patients-with-multiple-myeloma-treated-with-thalidomide/)
- [Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone](https://scholariq.org/papers/improved-survival-and-complete-response-rates-in-patients-with-advanced-melanoma/)
- [Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant](https://scholariq.org/papers/dialysis-dependent-renal-failure-in-patients-with-myeloma-can-be-reversed-by/)
- [Thalidomide and Deep Vein Thrombosis in Multiple Myeloma: Risk Factors and Effect on Survival](https://scholariq.org/papers/thalidomide-and-deep-vein-thrombosis-in-multiple-myeloma-risk-factors-and-effect/)
- [Beyond the CRAB Symptoms: A Study of Presenting Clinical Manifestations of Multiple Myeloma](https://scholariq.org/papers/beyond-the-crab-symptoms-a-study-of-presenting-clinical-manifestations-of/)
- [Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment](https://scholariq.org/papers/pomalidomide-dexamethasone-and-daratumumab-in-relapsed-refractory-multiple/)
- [Clinical and biological features of multiple myeloma involving the gastrointestinal system.](https://scholariq.org/papers/clinical-and-biological-features-of-multiple-myeloma-involving-the/)
- [Avascular Necrosis of Femoral and/or Humeral Heads in Multiple Myeloma: Results of a Prospective Study of Patients Treated With Dexamethasone-Based Regimens and High-Dose Chemotherapy](https://scholariq.org/papers/avascular-necrosis-of-femoral-and-or-humeral-heads-in-multiple-myeloma-results/)
- [Parenteral replacement therapy with iron dextran or ferumoxytol in patients with iron deficiency](https://scholariq.org/papers/parenteral-replacement-therapy-with-iron-dextran-or-ferumoxytol-in-patients-with/)

## Researcher topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Cancer Mechanisms and Therapy](https://scholariq.org/topics/cancer-mechanisms-and-therapy/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Researcher university

- [SUNY Upstate Medical University](https://scholariq.org/institutions/suny-upstate-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.